| 2026-07-13 09:10 |
8-K |
["1.01", "1.02"] |
merger agreement |
1.00
|
Merger between Esperion and Essence Parent consummated July 13, 2026; Esperion is now wholly owned subsidiary. |
SEC · detail |
| 2026-07-08 08:32 |
8-K |
["5.07"] |
merger agreement |
0.98
|
Stockholders approved merger agreement with Essence Parent Inc.; MergerCo to merge with Esperion as surviving subsidiary. |
SEC · detail |
| 2026-06-18 16:04 |
8-K |
["9.01"] |
merger agreement |
1.00
|
Esperion completed acquisition of Corstasis per merger agreement dated March 2, 2026. |
SEC · detail |
| 2026-06-16 16:00 |
8-K |
["8.01"] |
merger agreement |
0.98
|
Esperion merger with ArchiMed affiliate approved by HSR; stockholder vote scheduled July 8, 2026. |
SEC · detail |
| 2026-06-09 16:01 |
8-K |
["8.01"] |
merger agreement |
0.98
|
Esperion merger with ArchiMed affiliate cleared by German antitrust; stockholder vote scheduled July 8, 2026. |
SEC · detail |
| 2026-06-08 06:02 |
DEFM14A |
|
merger agreement |
0.99
|
Definitive proxy statement for completed merger agreement: Esperion acquired by ArchiMed affiliate for $3.16/share + contingent payments. |
SEC · detail |
| 2026-06-01 16:22 |
8-K |
["5.02", "5.07", "9.01"] |
other |
0.05
|
Routine annual meeting results; no M&A signals detected. |
SEC · detail |
| 2026-05-29 17:17 |
PREM14A |
|
merger agreement |
0.98
|
Esperion entering definitive merger with ArchiMed affiliate at $3.16/share plus contingent payments. |
SEC · detail |
| 2026-05-01 07:55 |
8-K |
["1.01"] |
merger agreement |
0.98
|
Esperion entered definitive merger agreement with Essence Parent Inc.; $3.16/share cash plus CVR with up to $100M contingent payments. |
SEC · detail |